Compare BMRN & NBY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BMRN | NBY |
|---|---|---|
| Founded | 1996 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.0B | 398.2M |
| IPO Year | 1999 | 2007 |
| Metric | BMRN | NBY |
|---|---|---|
| Price | $59.78 | $0.55 |
| Analyst Decision | Buy | |
| Analyst Count | 21 | 0 |
| Target Price | ★ $89.86 | N/A |
| AVG Volume (30 Days) | ★ 2.1M | 1.9M |
| Earning Date | 02-20-2026 | 04-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 59.53 | N/A |
| EPS | ★ 2.68 | 0.47 |
| Revenue | ★ $3,094,001,000.00 | $10,302,000.00 |
| Revenue This Year | $13.53 | $23.91 |
| Revenue Next Year | $9.69 | $32.05 |
| P/E Ratio | ★ $22.36 | $23.40 |
| Revenue Growth | 12.39 | ★ 390.34 |
| 52 Week Low | $50.76 | $0.46 |
| 52 Week High | $73.51 | $19.95 |
| Indicator | BMRN | NBY |
|---|---|---|
| Relative Strength Index (RSI) | 63.45 | 35.04 |
| Support Level | $57.84 | $0.57 |
| Resistance Level | $61.48 | $0.72 |
| Average True Range (ATR) | 1.69 | 0.32 |
| MACD | 0.36 | -0.21 |
| Stochastic Oscillator | 85.00 | 1.54 |
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.
NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.